期刊文献+

口服脊髓灰质炎减毒活疫苗中庆大霉素残留量检测方法的验证

The validation of residual gentamicin detection method in live attenuated oral poliovirus vaccine
原文传递
导出
摘要 目的验证口服脊髓灰质炎减毒活疫苗(人二倍体细胞)中庆大霉素残留量的检测方法。方法应用庆大霉素ELISA试剂盒建立庆大霉素残留量的检测方法。对该方法标准曲线的线性,线性范围内的准确度、精密度、专属性、耐用性、检测限及定量限进行验证。结果验证的标准曲线线性良好,相关系数〉0.98。该法检测高、中、低浓度的庆大霉素标准品的回收率为92.7%~123.6%;检测同一批次供试品的相对标准偏差为8oA;不同实验人员检测同一批次供试品和不同批次试剂盒检测同一批次供试品,相对标准偏差均〈15%;庆大霉素加样回收率为95.9%~121.3%;该法在(37±1)℃温度范围内耐用性良好;该法测定庆大霉素的检测限为0.040ng/ml,定量限为0.135ng/ml。结论用于检测口服脊髓灰质炎减毒活疫苗(人二倍体细胞)中庆大霉素残留量的方法是有效的。 Objective To verify the detection method of residual gentamicin in the live attenuated oral poliovirus vaccine (human diploid cell). Method Gentamicin ELISA kit was used to establish a method for the determination of gentamicin residues. The linearity of the standard curve of the method and the accuracy, precision, specificity, durability, detection and quantitative limits of the linear range were verified. Results The standard curve of the test was linear, with correlation coefficient 〉0. 98. The recovery rates of the high, medium and low concentrations of gentamicin were 92. 7%-123. 6%. The relative standard deviation of same batch samples tested was 8%. The relative standard deviations of same batch samples tested by different test personnel and different batches of test kits were all 〈15%. The recovery rates of gentamicin were 95. 9%-121. 3%. The method had good durability in the temperature range of (37±1)℃. The detection limit of gentamicin was 0. 040 ng/ml and the quantitative limit was 0. 135 ng/ml. Conclusion The method is effective for the detection of gentamycin in live attenuated oral poliovirus vaccine (human diploid cell).
作者 李占辉 王为 高静 武京红 杨冰 栗妍 李丽 Li Zhanhui;Wang Wei;Gao Jing;Wu Jinghong;Yang Bing;Li ]ran;Li Li.(Quality Inspection Department, Beijing Bio-lnstitute Biological Products Co., Ltd., Beijing 100176, China)
出处 《国际生物制品学杂志》 CAS 2018年第3期110-112,122,共4页 International Journal of Biologicals
关键词 脊髓灰质炎病毒疫苗 口服 庆大霉素类 药物残留物 酶联免疫吸附测定 验证 Poliovirus vaccine,oral Gentamycins Drug residues Enzyme-linked immunosorbentassay Validation
  • 相关文献

参考文献2

二级参考文献6

  • 1WHO MediaCentre.Poliomtelitis[R].Geneva:WHO 2014,No.114. 被引量:1
  • 2World Health Organization.Guidelines on stability evaluation of vaccines[R].Geneva:WHO,2006,23-27. 被引量:1
  • 3World Health Organization.Guidelines for clinical evaluation of vaccines:regulatory expectations[R].Geneva:WHO Technical Report Series,2004,No.924,Annex 1. 被引量:1
  • 4World Health Organization.Guidelines on nonclinical evaluation of vaccines[R].Geneva:WHO TechnicalReport Series,2005,No.927. 被引量:1
  • 5World Health Organization.Recommendations to assure the quality,safety and efficacy of live attenuated poliomyelitis vaccine(oral)[R].Geneva:WHO,2012,Annex1. 被引量:1
  • 6北京天坛生物制品股份有限公司.YBS00022013口服脊髓灰质炎减毒活疫苗(人二倍体细胞)注册标准[S].北京:北京天坛生物制品股份有限公司,2013. 被引量:1

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部